Enzon Pharmaceuticals, Inc.
ENZN
$0.0998
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.86M | 46.63M | 46.23M | 45.99M | 47.01M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 293.00K | 337.00K | 409.00K | 481.00K | 331.00K |
| Total Current Assets | 47.15M | 46.97M | 46.64M | 46.47M | 47.34M |
|
|
|||||
| Total Current Assets | 47.15M | 46.97M | 46.64M | 46.47M | 47.34M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.00K | 306.00K | 356.00K | 360.00K | 359.00K |
| Total Assets | 47.17M | 47.28M | 46.99M | 46.83M | 47.70M |
|
|
|||||
| Total Accounts Payable | 331.00K | 331.00K | 331.00K | 331.00K | 331.00K |
| Total Accrued Expenses | 67.00K | 101.00K | 59.00K | 184.00K | 92.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.28M | 6.00K | 20.00K | 6.00K | 1.29M |
| Total Other Current Liabilities | 1.28M | 6.00K | 20.00K | 6.00K | 1.29M |
| Total Current Liabilities | 1.68M | 438.00K | 410.00K | 521.00K | 1.71M |
|
|
|||||
| Total Current Liabilities | 1.68M | 438.00K | 410.00K | 521.00K | 1.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.68M | 438.00K | 410.00K | 521.00K | 1.71M |
|
|
|||||
| Common Stock & APIC | 72.90M | 72.58M | 73.11M | 73.64M | 74.18M |
| Retained Earnings | -69.89M | -69.82M | -70.07M | -70.35M | -70.67M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.01M | 2.76M | 3.04M | 3.29M | 3.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 42.48M | 44.08M | 43.55M | 43.01M | 42.48M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 42.48M | 44.08M | 43.55M | 43.01M | 42.48M |
|
|
|||||
| Total Common Equity | 3.01M | 2.76M | 3.04M | 3.29M | 3.51M |
| Total Preferred Equity | 42.48M | 44.08M | 43.55M | 43.01M | 42.48M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.49M | 46.84M | 46.58M | 46.31M | 45.99M |
|
|
|||||